Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia

2014 ◽  
Vol 29 (2) ◽  
pp. 199-202 ◽  
Author(s):  
Itaru Miura ◽  
Tetsuya Shiga ◽  
Akihiko Katsumi ◽  
Keiko Kanno-Nozaki ◽  
Hirobumi Mashiko ◽  
...  
Keyword(s):  
Monoamine Metabolites

Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease

1987 ◽  
Vol 91 (3) ◽  
pp. 293-296 ◽  
Author(s):  
T. Sunderland ◽  
P. N. Tariot ◽  
R. M. Cohen ◽  
P. A. Newhouse ◽  
A. M. Mellow ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Monoamine Metabolites ◽  
Dose Dependent

Effect of age on cisternal cerebrospinal fluid concentrations of monoamine metabolites in nonhuman primates

1988 ◽  
Vol 13 (3) ◽  
pp. 353-357 ◽  
Author(s):  
Steven E. Shelton ◽  
Ned H. Kalin ◽  
John P. Gluck ◽  
Michael F. Keresztury ◽  
Vicki A. Schneider ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Nonhuman Primates ◽  
Monoamine Metabolites ◽  
Effect Of Age

CSF monoamine metabolites in old age dementias

1992 ◽  
Vol 16 (1-2) ◽  
pp. 143-157 ◽  
Author(s):  
Lucilla Parnetti ◽  
Alberto Gaiti ◽  
Gian Paolo Reboldi ◽  
Carla Santucci ◽  
Patrizia Mecocci ◽  
...  
Keyword(s):  
Old Age ◽  
Monoamine Metabolites

Decreased Spinal Fluid Monoamine Metabolites and Norepinephrine in Schizophrenic Patients with Brain Atrophy

1985 ◽  
pp. 88-95 ◽  
Author(s):  
D. P. Van Kammen ◽  
Lee S. Mann ◽  
Mika Scheinin ◽  
Philip T. Ninan ◽  
Welmoet B. Van Kammen ◽  
...  
Keyword(s):  
Brain Atrophy ◽  
Spinal Fluid ◽  
Monoamine Metabolites ◽  
Schizophrenic Patients
Sign in / Sign up

Export Citation Format

Share Document